HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haloperidol both prevents and reverses quinpirole-induced nonregulatory water intake, a putative animal model of psychogenic polydipsia.

AbstractRATIONALE:
Polydipsia is a severe complication of long-term schizophrenia and, despite its unknown pathogenesis, is empirically treated with typical or atypical antipsychotics. In the rat, nonregulatory water intake is induced by repeated administration of amphetamine-like compounds or by the D2/3 agonist, quinpirole.
OBJECTIVE:
This study is aimed at determining the potential activity of antipsychotic compounds with different affinities for D2 receptors in preventing and/or reversing quinpirole-induced polydipsia.
MATERIALS AND METHODS:
Male Sprague-Dawley rats were treated with five injections of quinpirole (0.5 mg/kg i.p.) to induce polydipsia. The oral effects of haloperidol, olanzapine, clozapine, and ST2472 on QNP-induced polydipsia were analyzed in the following two schedules. In the preventive schedule, haloperidol (0.2, 0.4, and 0.8 mg/kg), olanzapine (1.5, 3, and 6 mg/kg), ST2472 (1 and 2 mg/kg), and clomipramine (5, 10, and 20 mg/kg) were given in combination with quinpirole from day 1 to day 5. In the reversal schedule, rats showing quinpirole-induced polydipsia on the third day received haloperidol (0.4 mg/kg), olanzapine (1.5 and 3 mg/kg), clozapine (10, 20, and 40 mg/kg), ST2472 (1, 2, 5, and 10 mg/kg), and clomipramine (5, 10, and 20 mg/kg) before quinpirole on days 4 and 5.
RESULTS:
Haloperidol both prevented and reversed quinpirole-induced polydipsia, whereas olanzapine and ST2472 only reversed it. Clomipramine prevented but did not reverse quinpirole-induced polydipsia, and clozapine did not reverse it either.
CONCLUSIONS:
We suggest that, once developed, polydipsia is governed by dopaminergic D2 mechanisms. In contrast, either an increase in the serotoninergic tone or an inhibition of D2 receptors can modulate the development of quinpirole-induced excessive drinking.
AuthorsDavide Amato, Maria Antonietta Stasi, Franco Borsini, Paolo Nencini
JournalPsychopharmacology (Psychopharmacology (Berl)) Vol. 200 Issue 2 Pg. 157-65 (Oct 2008) ISSN: 0033-3158 [Print] Germany
PMID18597076 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • 9-piperazin-1-ylpyrrolo(2,1-b)benzothiazepine
  • Antipsychotic Agents
  • Piperazines
  • Pyrroles
  • Receptors, Dopamine D2
  • Thiazepines
  • Benzodiazepines
  • Quinpirole
  • Clozapine
  • Haloperidol
  • Olanzapine
  • Clomipramine
Topics
  • Administration, Oral
  • Animals
  • Antipsychotic Agents (administration & dosage, pharmacology)
  • Benzodiazepines (administration & dosage, pharmacology)
  • Clomipramine (administration & dosage, pharmacology)
  • Clozapine (administration & dosage, pharmacology)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drinking (drug effects)
  • Haloperidol (administration & dosage, pharmacology)
  • Male
  • Olanzapine
  • Piperazines (administration & dosage, pharmacology)
  • Pyrroles (administration & dosage, pharmacology)
  • Quinpirole
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D2 (drug effects, metabolism)
  • Thiazepines (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: